For The Better

The best part? It doesn’t require much research at all.

What to watch for in this week’s announcement.

The pharmaceutical is a high-quality dividend stock that offers investors tremendous growth at a reasonable price.

Now’s the ideal time for Roth IRA conversions. Here’s how to know if this move is right for you.

Great companies trading at cheap prices? Yes, please.

A return to in-person events and a celebrity hire are pushing Revolve Group to new heights.

On episode XXIII of In the Know, ARK CEO/CIO, Cathie Wood, weighs in on the bond market, inventory overhangs, the latest employment report…

The automaker was the top seller in November

The besieged mobility platform’s investors have another headache to contend with.

An outspoken bear says the sportsbook operator’s business model is flawed.

Earnings were good, but the market is punishing high-growth but richly valued stocks right now.

Shiba Inu isn’t the only meme token in town, that’s for sure.

More signs of high inflation sticking around and rate hikes, coupled with the scare from the omicron coronavirus variant, have led to a massive sell-off in fintech stocks this week.

The design for the Neutron has been revealed, and any further excitement is likely to be way down the road.

Canadian marijuana stocks didn’t fare well this week.

The stock market sell-off hit these hydrogen fuel-cell stocks hard.

HIBB earnings call for the period ending October 30, 2021.

A down market isn’t helping Dogecoin’s free fall today.

Uranium prices keep declining, and they’re taking uranium stocks down with them.